EP HIV-1090
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP HIV-1090, covering 2007-12-24 to 2007-12-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) [Phase 1]